Teikoku takes on buccal fentanyl in Japan as Taiho rejigs priorities
This article was originally published in Scrip
Executive Summary
Teikoku Seiyaku's well-established presence in Japan's analgesic sector has proven attractive to Taiho Pharmaceutical, which has agreed to partly transfer to the firm its local rights to OVF, a buccal formulation of fentanyl citrate.